It is important to investigate the impacts of drugs beyond what they can achieve alone. Using them in combination can act as a multiplier and increase the sum of their benefits.
Achieving synergistic effects, fighting resistance
The complexity of cancer underscores the need for a variety of treatment approaches, which is why a combination of one or more therapeutic interventions is often used to battle cancer. Combination therapy might achieve efficacy with lower doses or less toxic drugs. It can chemo-sensitise cells, making an additional compound more potent. It can have additive or synergistic effects, minimise drug resistance, or fight against expected resistance. Although monotherapy is still a common approach, it is often deemed that even better results could potentially be obtained when these therapies will become rationally combined with others.
Targeting cancer’s escape route
Methods to eradicate cancer cells have evolved from surgery, radiotherapy and chemotherapy to therapies targeting the tumour micro-environment, such as immunotherapy. New insights into how we can influence, control and limit tumour growth leads to the potential of combination therapies. Combining several interventions attacks multiple tumour pathways at the same time, enhancing the overall impact on tumour growth.
Our trials in this focus area
Our current focus areas
Drug repurposingDrug repurposing, also known as drug repositioning, is a drug development strategy predicated on the reuse of existing...
Less common and rare cancersWe don’t just focus on the ‘big four’ of cancer – prostate, colon, breast and lung. We also investigate new treatment...
Combination therapiesIt is important to investigate the impacts of drugs beyond what they can achieve alone. Using them in combination can...
Preventing tumour recurrenceFor cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence, and living...
Ask for funding
We invest in the most promising research to make measurable progress in the fight against cancer.
We strive to improve survival and quality of life, financial return is not within the scope of our activities.
We identify untapped potential in cancer research leading to pragmatic solutions for patients in need.
We seek impact and we invest our resources where we believe we can make the most progress.
Every cancer deserves the same attention, regardless of prevalence or profitability.